These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 21116611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G, Dib J, Tretzel L, Piper T, Bosse C, Schänzer W, Thevis M.
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control.
    Cha E, Kim S, Kim HJ, Lee KM, Kim KH, Kwon OS, Lee J.
    Drug Test Anal; 2015; 7(11-12):1040-9. PubMed ID: 26489966
    [Abstract] [Full Text] [Related]

  • 4. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G, Koch A, Orlovius AK, Guddat S, Thomas A, Schänzer W, Thevis M.
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [Abstract] [Full Text] [Related]

  • 5. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S, Bornatsch W, Lagojda A, Schänzer W, Thevis M.
    Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
    [Abstract] [Full Text] [Related]

  • 6. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S, Heinrich G, Hemmersbach P.
    Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
    [Abstract] [Full Text] [Related]

  • 7. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G, Carius Garrido B, Dias Leal F, Costa Padilha M, Mazzarino M, de la Torre X, Botre F, Radler de Aquino Neto F.
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M, Milosovich S, Licea-Perez H, Knecht D, Cavalier T, Schänzer W.
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [Abstract] [Full Text] [Related]

  • 13. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W.
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [Abstract] [Full Text] [Related]

  • 14. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
    Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W.
    Eur J Mass Spectrom (Chichester); 2009 Apr; 15(4):507-15. PubMed ID: 19661559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
    Beuck S, Sigmund G, Koch A, Schänzer W, Pokrywka A, Kwiatkowska D, Thevis M.
    Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.